916 related articles for article (PubMed ID: 8470052)
21. Effects of OKY-046, a selective thromboxane synthetase inhibitor, on blood pressure and thromboxane synthesis in spontaneously hypertensive rats.
Gomi T; Ikeda T; Ishimitsu T; Uehara Y
Prostaglandins Leukot Essent Fatty Acids; 1989 Sep; 37(3):139-44. PubMed ID: 2608692
[TBL] [Abstract][Full Text] [Related]
22. An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension.
Christman BW; McPherson CD; Newman JH; King GA; Bernard GR; Groves BM; Loyd JE
N Engl J Med; 1992 Jul; 327(2):70-5. PubMed ID: 1603138
[TBL] [Abstract][Full Text] [Related]
23. [Urinary 11-dehydrothromboxane B2 and 6-keto-prostaglandin F1 alpha in normal pregnant women and in women complicated with pregnancy-induced hypertension].
Yoshimura T; Okazaki T; Suzuki A
Nihon Sanka Fujinka Gakkai Zasshi; 1992 Jun; 44(6):657-62. PubMed ID: 1506726
[TBL] [Abstract][Full Text] [Related]
24. Effects of a selective thromboxane synthetase inhibitor (OKY-046) in patients with coronary artery disease during exercise.
Shikano M; Ito T; Ogawa K; Satake T
Jpn Heart J; 1987 Sep; 28(5):663-74. PubMed ID: 3323562
[TBL] [Abstract][Full Text] [Related]
25. Thromboxane and prostacyclin biosynthesis in patients with acute spontaneous intracerebral hemorrhage.
Saloheimo P; Juvela S; Riutta A; Pyhtinen J; Hillbom M
Thromb Res; 2005; 115(5):367-73. PubMed ID: 15733969
[TBL] [Abstract][Full Text] [Related]
26. Prostacyclin and thromboxane in pregnant and nonpregnant women in response to exercise.
Rauramo I; Ilmonen S; Viinikka L; Ylikorkala O
Obstet Gynecol; 1995 Jun; 85(6):1027-30. PubMed ID: 7770249
[TBL] [Abstract][Full Text] [Related]
27. Prevention of endotoxin-induced pulmonary hypertension in primates by the use of a selective thromboxane synthetase inhibitor, OKY 1581.
Casey LC; Fletcher JR; Zmudka MI; Ramwell PW
J Pharmacol Exp Ther; 1982 Aug; 222(2):441-6. PubMed ID: 6896528
[TBL] [Abstract][Full Text] [Related]
28. Platelet function during acetaldehyde intoxication in healthy male volunteers.
Neiman J; Hillbom M; Jones AW; Benthin G; Löwbeer C
Alcohol Alcohol Suppl; 1987; 1():587-90. PubMed ID: 3426736
[TBL] [Abstract][Full Text] [Related]
29. Effects of thromboxane A2 synthesis inhibitor (OKY-046) on total liver ischemia in rats.
Kobayashi T; Esato K; Morita N; Noshima NS
Int Surg; 1996; 81(2):115-8. PubMed ID: 8912073
[TBL] [Abstract][Full Text] [Related]
30. Effects of flunixin meglumine, phenylbutazone and a selective thromboxane synthetase inhibitor (UK-38,485) on thromboxane and prostacyclin production in healthy horses.
Hardee MM; Moore JN; Hardee GE
Res Vet Sci; 1986 Mar; 40(2):152-6. PubMed ID: 3517992
[TBL] [Abstract][Full Text] [Related]
31. Urinary excretion of prostaglandins and renal function after hepatic resection.
Matsumata T; Yamamoto K; Shirabe K; Shimada M; Sugimachi K; Takesue F; Muto Y; Ikeda T
Hepatogastroenterology; 1997; 44(15):774-8. PubMed ID: 9222688
[TBL] [Abstract][Full Text] [Related]
32. Prostacyclin and thromboxane A2 synthesis are increased in acute lower limb ischaemia.
Rossi P; Kuukasjärvi P; Riutta A; Salenius JP; Tarkka M; Mucha I; Kerttula T; Alanko J
Prostaglandins Leukot Essent Fatty Acids; 1996 Dec; 55(6):433-6. PubMed ID: 9014222
[TBL] [Abstract][Full Text] [Related]
33. Urinary excretion of prostacyclin and thromboxane metabolites in threatened preterm labor: effect of indomethacin and nylidrin.
Kurki T; Viinikka L; Ylikorkala O
Am J Obstet Gynecol; 1992 Jan; 166(1 Pt 1):150-4. PubMed ID: 1733190
[TBL] [Abstract][Full Text] [Related]
34. Effects of low-to-high doses of aspirin on platelet aggregability and metabolites of thromboxane A2 and prostacyclin.
Tohgi H; Konno S; Tamura K; Kimura B; Kawano K
Stroke; 1992 Oct; 23(10):1400-3. PubMed ID: 1412574
[TBL] [Abstract][Full Text] [Related]
35. Thromboxane synthesis inhibition increases renal prostacyclin and prevents renal disease progression in rats with remnant kidney.
Zoja C; Perico N; Corna D; Benigni A; Gabanelli M; Morigi M; Bertani T; Remuzzi G
J Am Soc Nephrol; 1990 Nov; 1(5):799-807. PubMed ID: 2133429
[TBL] [Abstract][Full Text] [Related]
36. Changes of systemic prostacyclin and thromboxane A2 in sodium taurocholate- and cerulein-induced acute pancreatitis in rats.
Closa D; Rosello-Catafau J; Martrat A; Hotter G; Bulbena O; Fernandez-Cruz L; Gelpi E
Dig Dis Sci; 1993 Jan; 38(1):33-8. PubMed ID: 7678383
[TBL] [Abstract][Full Text] [Related]
37. Human pharmacology of naproxen sodium.
Capone ML; Tacconelli S; Sciulli MG; Anzellotti P; Di Francesco L; Merciaro G; Di Gregorio P; Patrignani P
J Pharmacol Exp Ther; 2007 Aug; 322(2):453-60. PubMed ID: 17473175
[TBL] [Abstract][Full Text] [Related]
38. Increased in vivo biosynthesis of prostacyclin and thromboxane A2 in chronic idiopathic thrombocytopenic purpura.
Rousson D; Guichardant M; Lagarde M; Viala JJ; Dechavanne M
Br J Haematol; 1989 Jul; 72(3):402-6. PubMed ID: 2669929
[TBL] [Abstract][Full Text] [Related]
39. The effects of a thromboxane A2 synthesis inhibitor and a prostaglandin I2 analogue on experimental acute necrotizing pancreatitis in rats.
Iida T; Yokoi H; Kawarada Y
Pancreas; 1998 Aug; 17(2):140-7. PubMed ID: 9700944
[TBL] [Abstract][Full Text] [Related]
40. Increased production of eicosanoids, TXA2, PGI2 and LTC4 in experimental spinal cord injuries.
Mitsuhashi T; Ikata T; Morimoto K; Tonai T; Katoh S
Paraplegia; 1994 Aug; 32(8):524-30. PubMed ID: 7970857
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
